Z-2311-2008
Stryker Biotech OP- 1 Implant is indicated for use as an alternative to autograft in recalcitrant long bone...
Stryker Biotech / initiated 2008-06-24 / Terminated / root cause: labeling and UDI
Stryker Biotech began a recall of Stryker Biotech OP- 1 Implant is indicated for use as an alternative to autograft in recalcitrant long bone nonunions where use of autograft is unfeasible and... on . The reason FDA records is "Product Package Insert misprint-text offset". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.
Recall record
- Recall number
- Z-2311-2008
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Stryker Biotech
- Product
- Stryker Biotech OP- 1 Implant is indicated for use as an alternative to autograft in recalcitrant long bone nonunions where use of autograft is unfeasible and alternative treatments have failed. Catalog Number: 100-25
- Product code
- MPW Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold, Osteoinduction
- Reason for recall
- Product Package Insert misprint-text offset
- Root cause tag
- labeling and UDI
- FDA root cause
- Error in labeling
- Action
- Stryker Biotech notified by letter dated June 24, 2008 via UPS Certified Mail. Physician letters were mailed 30 Jun 2008 and IRB letters were mailed July 01, 2008; letters included a correctly printed package insert. Contact Judith Sernatinger at 508-416-5200 if you have questions.
- Quantity in commerce
- 803 units
- Distribution
- Nationwide
- Product codes and lots
- Lots Numbers: FC0803004, FC0803005, FC0804002, FC0804007, FCO804010, FC0805002, FC0805003, and FC0805004
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
